CD8A and neoplasm: As a result, the recognition of tumor-associated antigens or neoantigens by effector CD8+ T cells through MHC class I molecule and TCR interaction was hindered, rendering the tumor cells less recognizable and less sensitive to lysis (7, 10, 161, 187).